Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jennifer Demorin"'
Autor:
Kirsten L. White, Damian J McColl, Edwin DeJesus, Christian Callebaut, David Piontkowsky, Hui Wang, Martin S. Rhee, Paul E. Sax, Jennifer Demorin, Erin Quirk, Moupali Das, David A. Wohl, Calvin J. Cohen
Publikováno v:
Antiviral Therapy. 23:95-99
We address a data gap identified by Adams et al., of virological efficacy outcomes and emergent drug resistance in HIV-1-infected, antiretroviral treatment (ART)-naive participants with baseline (BL) viral loads (VL) >1,000,000 copies/ml. Initial ART
Autor:
Georg Behrens, Jennifer Demorin, Simon Vanveggel, Susan K. Chuck, Calvin J. Cohen, Bart J. A. Rijnders, Marita Stevens, Richard Elion, David Thorpe, Laurence T. Rimsky, Chloe Orkin, Mark T. Nelson, Anthony Mills, Matthew Bosse, Lijie Zhong, Kirsten L. White
Publikováno v:
AIDS Patient Care and STDs, 28(4), 168-175. Mary Ann Liebert Inc.
The once daily, single-tablet regimen (STR) combining rilpivirine (RPV), emtricitabine (FTC), and tenofovir disoproxil fumarate (TDF) provides a simplified treatment option for antiretroviral therapy (ART)-naive patients with baseline HIV-1 RNA (BLVL
Autor:
David Piontkowsky, Sun Jin Hwang, Mark T. Nelson, Jun Yong Choi, Hui C. Liu, Christopher Ng, Paul E. Sax, Sang Youn Yang, Howard Edelstein, Thanomsak Anekthananon, Somnuek Sungkanuparph, Raji Swamy, Edwin DeJesus, Jennifer Demorin, Joonwoo Bahn
Publikováno v:
Infection & Chemotherapy
The efficacy and safety of a single tablet regimen (STR) of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) were analyzed in Phase 3 clinical trials in antiretroviral therapy (ART)-naïve and ART-experienced Asian subj
Autor:
Felipe Rogatto, Jennifer Demorin, Martin S. Rhee, Giovanni Di Perri, Brian Gazzard, Joel E. Gallant, William J. Towner, Javier Szwarcberg, Damian J McColl, Pierre Marie Girard, H Liu, David Piontkowsky
Publikováno v:
Journal of the International AIDS Society
Introduction : In high-income countries, ≥30% of HIV-infected patients are ≥50 years (yrs) old (UNAIDS 2013). In two phases, three clinical trials (Studies 102 and 103) elvitegravir/cobicistat/emtricitabine/tenofovir DF (E/C/F/TDF; STB) had non-i